| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| venetoclax and obinutuzumab | 1.92 | 1 | 6649 | 3 | 27 |
| venetoclax | 0.39 | 1 | 9656 | 99 | 10 |
| and | 1.18 | 1 | 6776 | 10 | 3 |
| obinutuzumab | 1.91 | 0.6 | 4412 | 9 | 12 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| venetoclax and obinutuzumab | 0.41 | 0.3 | 7711 | 39 |
| venetoclax and obinutuzumab cll | 0.99 | 0.2 | 8257 | 44 |
| venetoclax and obinutuzumab side effects | 1.12 | 0.2 | 9332 | 94 |
| venetoclax and obinutuzumab protocol | 1.47 | 0.5 | 2640 | 63 |
| venetoclax and obinutuzumab regimen | 0.22 | 0.5 | 4776 | 36 |
| venetoclax and obinutuzumab eviq | 0.06 | 0.7 | 9638 | 72 |
| venetoclax and obinutuzumab nejm | 2 | 0.1 | 6278 | 99 |
| venetoclax and obinutuzumab nice | 0.89 | 0.2 | 5979 | 69 |
| obinutuzumab venetoclax protocol | 1.28 | 0.8 | 3426 | 29 |
| obinutuzumab venetoclax relapsed cll | 0.63 | 0.5 | 4496 | 13 |
| comparison between obinutuzumab venetoclax | 0.48 | 0.6 | 6531 | 96 |
| obinutuzumab venetoclax nssg | 0.69 | 0.9 | 7043 | 44 |
| cll venetoclax obinutuzumab | 1.94 | 0.5 | 4320 | 75 |
| venetoclax obinutuzumab | 0.36 | 0.8 | 4875 | 61 |
